Biofil Chemicals & Pharmaceuticals Ltd.

Financial

	Biofil Chem & Pharma	Rite Zone Chemcon	Amal
Operational Metrics
Financials
5 yr Average ROE	5.35 %	9.36 %	10.32 %
5yr average Equity Multiplier	1.92	6.2	1.9
5yr Average Asset Turnover Ratio	0.98	0.76	0.59
5yr Avg Net Profit Margin	2.92 %	2.83 %	8.35 %
Price to Book	6.22	0.0	7.23
P/E	164.64	25.46	296.2
5yr Avg Cash Conversion Cycle	95.25 Days	62.39 Days	6.32 Days
Inventory Days	25.44 Days	0.35 Days	14.56 Days
Days Receivable	168.17 Days	147.85 Days	16.21 Days
Days Payable	169.49 Days	283.46 Days	68.04 Days
5yr Average Interest Coverage Ratio	18.5	5.19	5.69
5yr Avg ROCE	7.83 %	8.41 %	15.62 %
5yr Avg Operating Profit Margin	5.83 %	10.27 %	22.78 %
5 yr average Debt to Equity	0.06	2.41	0.57
5yr CAGR Net Profit	3.13 %	38.99 %	n/a
5yr Average Return on Assets	2.82 %	2.22 %	7.31 %
Shareholdings
Promoter Holding	46.82 %	41.89 %	71.33 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	5.19 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Biofil Chem & Pharma	Rite Zone Chemcon	Amal
Product Wise Break-Up	Product Wise Break-Up Chemicals 64.4 Pharmaceuticals 35.6 Sulphur dioxide 0 oleum 0 sulphuric acid 0 Steam 0 Chemicals 0	-	Product Wise Break-Up Pharmaceuticals 0 oleum 0 Sulphur dioxide 0 Steam 15.63 sulphuric acid 0 Chemicals 84.37
Operating Profit Break-Up	Operating Profit Break-Up Chemicals 100.0 Pharma Div 0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise Chemical 53.05 Pharma 46.95	-	-